Mothers' anxiety during pregnancy is associated with asthma in their children  by Cookson, Hannah et al.
Mothers’ anxiety during pregnancy is associated with
asthma in their children
Hannah Cookson, MB, ChB,a Raquel Granell, PhD,b Carol Joinson, PhD,c Yoav Ben-Shlomo, PhD,b
and A. John Henderson, MDc Perth, Australia, and Bristol, United KingdomBackground: Maternal stress in early life has been associated
with the development of asthma in children, although it is
unclear whether there are any critical periods of exposure. The
association of asthma with prenatal exposure to maternal stress
has not been reported.
Objective: We tested whether prenatal and postnatal anxiety
and/or depression in pregnant women predicted the risk of their
offspring developing asthma in childhood.
Methods: The Avon Longitudinal Study of Parents and Children
is a population-based birth cohort recruited during pregnancy.
Data were available on maternal anxiety scores and asthma at
age 7½ years in 5810 children. Anxiety was assessed at 18 and 32
weeks of gestation by using the validated Crown-Crisp
Experiential Index. Asthma was defined at age 7½ years as
doctor-diagnosed asthma with current symptoms or treatment
in the previous 12 months. Multivariable logistic regression was
used to determine the association of prenatal anxiety with
asthma (odds ratio; 95% CI).
Results: Independent of postnatal anxiety and adjusted for a
number of likely confounders, there was a higher likelihood of
asthma at age 7½ years (odds ratio, 1.64; 95% CI, 1.25-2.17) in
children of mothers in the highest compared with lowest
quartile of anxiety scores at 32 weeks of gestation, with evidence
for a dose-response (P value for trend <0.001).
Conclusions: Maternal anxiety symptoms as an indicator of stress
during fetal life may program the development of asthma during
childhood. (J Allergy Clin Immunol 2009;123:847-853.)
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Asthma is an important health problem that accounts for an
estimated annual healthcare budget in the United Kingdom of
£817.4 million ($1600.9 million; V1043.2 million).1 A high pro-
portion of asthma begins in childhood, but despite intense
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in children remain largely unknown.
Psychological and emotional factors are recognized to trigger
asthma exacerbations,2 and emotional stimuli have been shown to
cause increased respiratory resistance in asthma.3,4 Surveys of
adults and children have identified a high level of comorbidity be-
tween asthma and anxiety.5,6 This has been studied in the context of
impact on asthma control,7 symptom perception, and quality of
life,8 but there are few data on the temporal relationship of these
disorders and the possibility that there exists a causal link between
anxiety and asthma. It is conceivable that anxiety and asthma coex-
ist because of shared environmental influences, such as early child-
hood adversity,9 or that anxiety could act through a variety of
postulated pathways to alter the risk of asthma. Of particular inter-
est is the possibility that parental psychological state could influ-
ence disease risk in their children, possibly through influences on
corticotrophin-mediated stress responses. There is some evidence
to support an association of anxiety disorders with dysregulation
of corticotrophin releasing factor,10 and alteration of hypothal-
amo-pituitary-adrenal (HPA) axis regulation has been suggested
as a plausible pathway for reported associations between parental
stress and asthma or wheezing in children. Wright et al11 reported
an increase in early childhood wheezing in association with care-
giver stress in a high-risk cohort of infants, and Kozyrskyj et al12
have recently reported a positive association betweenmaternal dis-
tress and asthma in children in an unselected, population-based co-
hort. However, there are no human studies to date that have
investigated the association of prenatal maternal anxiety or depres-
sion with subsequent asthma in the offspring.
The existence of a programming effect of prenatal stress on
fetal development is supported by reports that adult mammals
exposed to prenatal stress have altered HPA13 and immune func-
tion14 after birth and may be predisposed to airway inflammation
and hyperresponsiveness.15 Maternal anxiety during pregnancy is
associated with raised blood cortisol levels in early pregnancy and
appears to strengthen the correlation between maternal blood and
amniotic fluid levels, possibly through an effect on placental func-
tion.16 Transplacental passage of cortisol could then have a pro-
gramming effect on HPA axis development in the fetus, leading
to alterations of stress responses after birth. The Avon Longitudi-
nal Study of Parents and Children (ALSPAC) studywas the first to
show in human beings that maternal anxiety levels during preg-
nancy were associated with alterations of cortisol responses mea-
sured 10 years later in preadolescent children.17
Abbreviations used
ALSPAC: Avon Longitudinal Study of Parents and Children
HPA: Hypothalamo-pituitary-adrenal
OR: Odds ratio847
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anxiety during pregnancy was associated with asthma in child-
hood. We were able to investigate this association in a large,
population-based birth cohort in which women’s reported anxiety
and depression were evaluated prospectively during pregnancy
and after the birth of their child and for which we had data on a
large range of potential confounding factors.
METHODS
Subjects were members of the ALSPAC, a population-based birth cohort
that recruited 14,541 pregnant women residents in Avon, United Kingdom,
with expected dates of delivery from April 1, 1991, to December 31, 1992.
There were 14,062 live born children, and 13,988 of these children were alive
at age 1 year and subsequently followed up. The cohort has been followed
since birth with annual questionnaires and, since age 7 years, with objective
measures in annual research clinics. The study protocol has been published
previously,18 and further details can be found at: http://www.bris.ac.uk/alspac.
Ethical approval for all measures was obtained from the ALSPAC Ethics and
Law Committee and from Local Research Ethics Committees.
Psychological measures
Anxiety symptoms were assessed using the anxiety subscale of the Crown-
Crisp Experiential Index, a validated self-rating inventory19 administered to
women during pregnancy as part of a self-completion questionnaire at 18
weeks and 32 weeks of gestation. Because some women were recruited after
18 weeks of gestation, eligibility for the current study was based on the avail-
ability of anxiety symptom data at 18 and 32weeks of gestation (n5 10,710 as
shown in Table I). Maternal anxiety symptoms were also assessed 8 months
after birth by using the same scale, and maternal depression symptoms were
assessed at these times using the Edinburgh Postnatal Depression Scale.20 A
life events inventory of 42 events was administered at 18 weeks of gestation
to the mother, from which a life events score was derived (see Methods and
Appendix E1 in the Online Repository at www.jacionline.org). Anxiety symp-
toms were measured in the mother’s partner at 18 weeks of gestation by using
the Crown-Crisp index, and a measure of the child’s anxiety was obtained
from the emotional symptoms subscale of the parent-reported Strengths and
Difficulties Questionnaire at 47 months.21
Outcomes
Current asthma at age 7½years was defined as a report of doctor’s diagnosis
of asthma ever and either reported symptoms of wheeze or treatment for
asthma in the previous 12 months on a questionnaire sent to mothers at 91
months after birth. Bronchial hyperresponsiveness was defined as a PD201.2
mg methacholine measured at 8 years using the method of Yan et al.22 Atopy
was defined as a positive response (2 mm weal) to any 1 of house dust mite
(Dermatophagoides pteronyssinus), grass, or cat allergen on skin prick test to a
panel of as many as 14 allergens at age 7 years. We have previously reported
that sensitization to 1 of these 3 allergens identifies more than 95% of those
with any positive skin test result.23
Confounders
Possible confounders or intermediaries of the relationship between mater-
nal anxiety and asthma in the child that were considered were the mother’s
age, education, history of asthma or allergy, and smoking during pregnancy, all
from maternal self-completion questionnaires. Maternal problems during
pregnancy (hypertension, diabetes, and steroid prescription); multiple preg-
nancy; and the child’s sex, gestation, and weight at delivery were ascertained
from maternal health records.
Analysis
Anxiety symptom scores were not normally distributed and were analyzed
as a categorical scale based on quartiles. The primary outcome was current
asthma at 7½ years, and secondary analyses were performed for asthma withbronchial hyperresponsiveness and atopic/nonatopic asthma, stratified ac-
cording to the criteria detailed. Odds ratios (ORs) and 95% CIs were
calculated by using logistic regression models with and without adjustment
for confounders.
Our analytical strategy attempted to differentiate between 2 classes of life
course models: a critical/sensitive period model versus an accumulation
model.24 We examined the strength of association between reported anxiety
symptoms and asthma in the prenatal and postnatal period with and without
mutual adjustment. We further defined 4 mutually exclusive exposure groups
on the basis of anxiety symptom scores above the median value for each pe-
riod. These were (1) no anxiety symptoms in either period (baseline group),
(2) prenatal only, (3) postnatal only, and (4) both prenatal and postnatal. We
postulated a priori that a prenatal critical periodmodel would show a similarly
increased risk for 2 and 4, whereas an accumulation model would find that 4
had the strongest association. We also attempted to differentiate between state
and trait anxiety symptoms by relating anxiety symptom scores to a life event
score derived from the life events inventory at 18 weeks of gestation. Mothers
in the lowest quartile were categorized to have anxiety trait and those in the
upper quartiles to have reactive anxiety.
To test for confounding ofmaternal prenatal effect by shared environmental
variables, analyses were adjusted for the mother’s partner’s self-reported
anxiety symptom scores during pregnancy. This should show an increased risk
through a common confounding factor—for example, adverse social circum-
stances—but could not influence intrauterine factors directly. Secondary
analyses were also adjusted for children’s scores on the emotional symptoms
subscale of the Strengths and Difficulties Questionnaire as a possible
intermediary between maternal anxiety and childhood asthma (see Methods
in the Online Repository at www.jacionline.org for full details).
Finally, to consider the possibility of reporting bias, associations between
maternal anxiety symptoms and reports of common childhood problems
(wheeze, earache, and accidents) were investigated (seeMethods in theOnline
Repository at www.jacionline.org).
All analyses were performed by using Stata v10 (StataCorp, College
Station, Tex).
RESULTS
Both antenatal questionnaires were completed by 10,710
women. Complete data on maternal prenatal anxiety symptom
scores at 18 and 32 weeks of gestation, asthma status of the
offspring at 7½ years, and all confounder variables were available
for 5810 (Fig 1). Mothers of children with incomplete data were
likely to be younger, to have lower educational attainment, to
smoke during pregnancy, and to report a personal history of
asthma than thosewith complete data. Theywere also more likely
to have higher anxiety symptom scores during and after preg-
nancy and higher depression symptom scores at 8 months after
birth (Table I). Children with incomplete data were more likely
to have lower birth weight, preterm delivery, and at least 1 sibling
than those with complete data.
The associations between maternal prenatal anxiety symptoms
and current asthma in children at 7½ years are shown in Table II.
There was an increased prevalence of asthma associated with
higher quartiles of anxiety symptom scores at both 18 and 32
weeks of gestation. There was only slight attenuation of the effect
sizes with adjustment, and there appeared to be evidence of a
dose-response gradient. For the more restrictive definition of
asthma with bronchial hyperresponsiveness, the association
with maternal anxiety symptoms at 32 weeks of gestation became
stronger, whereas at 18 weeks it became more modest, and only
the former showed a dose-response effect that was unlikely to
be the result of chance (adjustedP value5 .005). Thereweremar-
ginally greater effect sizes for anxiety symptoms not associated
with life events (anxiety trait) compared with those that were
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Original cohort N 5 10,710 Study population N 5 5,810* Incomplete N 5 4,900 P valuez
Prenatal measures
Main exposures
Maternal anxiety at 18 wk
1st quartile (0-2) 3,265 (30.5) 1,932 (33.3) 1,333 (27.2)
2nd quartile (3-4) 2,411 (22.5) 1,350 (23.2) 1,061 (21.7) <.001
3rd quartile (5-7) 2,814 (26.3) 1,495 (25.7) 1,319 (26.9)
4th quartile (8-16) 2,220 (20.7) 1,033 (17.8) 1,187 (24.2)
Maternal anxiety at 32 wk
1st quartile (0-2) 2,981 (27.8) 1,750 (30.1) 1,231 (25.1)
2nd quartile (3-4) 2,481 (23.2) 1,417 (24.4) 1,064 (21.7) <.001
3rd quartile (5-7) 2,836 (26.5) 1,512 (26.0) 1,324 (27.0)
4th quartile (8-16) 2,412 (22.5) 1,131 (19.5) 1,281 (26.1)
Confounders
Maternal age (mean [SD]) 28.4 (4.8) 29.2 (4.5) 27.4 (5.0) <.001
Low birth weight <2.5 kg 498/10,577 (4.7) 247 (4.3) 251/4,767 (5.3) .01
Sex (males) 5,539/10,709 (51.7) 2,985 (51.4) 2,554/4,899 (52.1) .4
Preterm <37 wk 599 (5.6) 296 (5.1) 303 (6.2) .02
Multiple birth 283 (2.6) 136 (2.3) 147 (3.0) .03
1 Sibling 5,862/10,603 (55.3) 3,127 (53.8) 2,735/4,793 (57.1) .001
Maternal low education 6,822/10,657 (64.0) 3,343 (57.5) 3,479/4,847 (71.8) <.001
Maternal asthma 1,166/10,265 (11.4) 610 (10.5) 556/4,455 (12.5) .002
Maternal allergy 4,411/10,224 (43.1) 2,551 (43.9) 1,860/4,414 (42.1) .07
Maternal smoking in pregnancy 3,459 (32.3) 1,505 (25.9) 1,954 (39.9) <.001
Diabetes during pregnancy 52 (0.5) 30 (0.5) 22 (0.4) .6
Hypertension during pregnancy 1,031 (9.6) 529 (9.1) 502 (10.2) .05
Steroids during pregnancy 60 (0.6) 29 (0.5) 31 (0.6) .4
Other exposures
Partner’s anxiety at 18 wk N 5 8,139 N 5 4,688 N 5 3,451
1st quartile (0-1) 3,089 (38.0) 1,778 (37.9) 1,311 (38.0)
2nd quartile (2) 1,341 (16.5) 752 (16.0) 589 (17.1) .6
3rd quartile (3-4) 1,744 (21.4) 1,011 (21.6) 733 (21.2)
4th quartile (5-16) 1,965 (24.1) 1,147 (24.5) 818 (23.7)
Postnatal measures
Main outcomes
Current asthma at 7½ y 781/6,129 (12.7) 735/5,810 (12.7) 46/319 (14.4) .4
Current asthma with bronchial
hyperresponsiveness
130/5,478 (2.4) 124/5,199 (2.4) 6/279 (2.2) .8
Atopic asthma 285/5,596 (5.1) 271/5,303 (5.1) 14/293 (4.9) .9
Nonatopic asthma 248/5,633 (4.4) 228/5,346 (4.3) 20/287 (6.8) .04
Other exposures
Maternal anxiety at 8 mo N 5 9,412 N 5 5,543 N 5 3,869
1st quartile (0-1) 3,087 (32.8) 1,864 (33.6) 1,223 (31.6)
2nd quartile (2-3) 2,689 (28.6) 1,615 (29.1) 1,074 (27.8) .001
3rd quartile (4-5) 1,590 (16.9) 933 (16.8) 657 (17.0)
4th quartile (6-16) 2,046 (21.7) 1,131 (20.4) 915 (23.6)
Maternal depression at 8 mo N 5 9,421 N 5 5552 N 5 3,869
1st quartile (0-2) 3,147 (33.4) 1,918 (34.5) 1,229 (31.8)
2nd quartile (3-4) 1,780 (18.9) 1,083 (19.5) 697 (18.0) <.001
3rd quartile (5-8) 2,504 (26.6) 1,472 (26.5) 1,032 (26.7)
4th quartile (9-29) 1,990 (21.1) 1,079 (19.4) 911 (23.5)
Children’s internalizing symptoms N 5 8,046 N 5 5,312 N 5 2,734
1st tertile (0-1) 4,940 (61.4) 3,284 (61.8) 1,656 (60.6)
2nd tertile (2) 1,457 (18.1) 959 (18.1) 498 (18.2) .5
3rd tertile (3-10) 1,649 (20.5) 1,069 (20.1) 580 (21.2)
n/N (%) corresponds to number of positive cases, total, and percentage (N as specified in column heading when not indicated).
*Children with data on maternal anxiety symptoms at both 18 and 32 weeks of gestation, current asthma at 7½ years, and all confounders.
Full time education up to and including General Certificate of Education (equivalent to school leaving certificate at age 16 y).
P value for t test for comparison of means or x2 test for comparison of proportions.(see this article’s Table E1 in the Online Repository at www.
jacionline.org), but there was little evidence of an interaction be-
tween maternal anxiety symptoms and life events on asthma risk
(P 5 .4).Analyses of asthma in children at 7½ years stratified by atopy
showed similar trends for higher maternal anxiety quartiles to be
associated with increased prevalence of both atopic and nonatopic
asthma in their children at age 7½ years (see this article’s Table E2
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ger evidence for dose-response relationships for maternal anxiety
symptoms reported at 32 weeks compared with 18 weeks, and ef-
fect sizes were greater for nonatopic compared with atopic
asthma. Post hoc analysis (multinomial logistic regression) pro-
vided weak evidence for a stronger effect of anxiety symptoms
at 18 weeks on nonatopic compared with atopic asthma (P 5
.05), but no evidence for a differential effect of anxiety symptoms
at 32weeks (P5.6). Therewas no strong evidence of associations
between maternal anxiety symptoms and either allergy or bron-
chial hyperresponsiveness alone (see this article’s Table E3 and
Table E4 in the Online Repository at www.jacionline.org).
To investigate the effects of timing of exposure, we considered
the associations between children’s asthma and maternal anxiety
symptom scores in the prenatal (32 weeks) and postnatal (8
months) periods with mutual adjustment (Table III). This showed
that only prenatal anxiety symptoms were strongly associated
with asthma in children after adjustment for postnatal anxiety
symptoms and other confounders. Further analysis of timing of
exposure showed that exposure in both prenatal and postnatal pe-
riods was more strongly associated with children’s asthma (OR,
1.46; 95% CI, 1.20-1.78) than during either prenatal (OR, 1.30;
95% CI, 1.04-1.64) or postnatal (OR, 1.18; 95% CI 0.89-1.57)
alone. However, further exploration of this relationship suggested
that, rather than an accumulation effect, duration of anxiety symp-
toms was a marker of prenatal severity so that women reporting
anxiety symptoms in both periods had higher anxiety scores at
32 weeks than those with anxiety symptoms at 32 weeks only,
and hence their anxiety symptoms were more likely to persist
FIG 1. Number (%) of participants who completed both antenatal
questionnaires on anxiety symptoms and had outcome data on child’s
asthma, bronchial responsiveness, and atopic status. BHR, bronchial
hyperresponsiveness.(see this article’s Table E5 in the Online Repository at
www.jacionline.org).
Adjustment for the mother’s partner’s anxiety symptoms at 18
weeks of gestation as a test for confounding of prenatal maternal
effects (see this article’s Table E6 in the Online Repository at
www.jacionline.org) showed no association between anxiety
symptoms and children’s asthma if only the partner reported anx-
iety symptoms (OR, 0.94; 95%CI, 0.73-1.20) compared with ma-
ternal anxiety symptoms alone (OR, 1.28; 95% CI, 1.00-1.63).
However, if both partners reported anxiety symptoms (above me-
dian score) at 18 weeks, the effect was stronger (OR, 1.33; 95%
CI, 1.04-1.68). This relationship was again confounded by sever-
ity of maternal anxiety symptoms because more anxious women
were more likely to have anxious partners (see this article’s Table
E7 in the Online Repository at www.jacionline.org).
There was no evidence that the association between maternal
anxiety symptoms and childhood asthma was mediated through
children’s internalizing symptoms because these did not attenuate
the effect of maternal anxiety. The OR (95% CI) for the highest
tertile of the emotional symptom subscale at 47 months (com-
pared with the lowest tertile) was 1.21 (0.98-1.48; P [trend] 5
0.1).
Finally, therewas no evidence that women with higher reported
anxiety symptom scores were more likely to present their child
with wheeze to a doctor in either early (6-18 months) or later (69-
81 months) childhood (highest vs lowest anxiety symptom score
at 32 weeks gestation: OR [95% CI], 1.19 [0.92-1.54] and 1.13
[0.81-1.58], respectively; see further details in this article’s Table
E8 in the Online Repository at www.jacionline.org).
DISCUSSION
The results of our study support a positive association between
maternal anxiety symptoms during pregnancy and subsequent
asthma in the offspring during childhood. The strength of the
associations, their consistency across different outcome mea-
sures, their robustness to adjustment for a wide range of
confounding or mediating variables, and the evidence for a
dose-response relationship raise the possibility that this associa-
tion may be causal, although its mechanism remains speculative.
Although others have reported links between maternal distress
and asthma in children,11,12 we believe this is the first report of an
association between antenatal exposure and subsequent asthma
during childhood.
Wright et al11 first reported the association of parental stress,
measured by using a 4-item scale of perceived stress by regular
telephone interview, and wheezing in infancy. More recently, a
study of maternal stress in early childhood in a large Canadian
population-based cohort reported an association with asthma at
age 7 years in their children.12 In this study, stress was defined
as a combination of depression and anxiety using health care uti-
lization data. The authors also reported a dose-response relation-
ship between the duration of exposure and the prevalence of
asthma and concluded that short-term exposure, limited to the first
year after birth, was not related to the subsequent development of
asthma. Consistent with our observations, therewas a relationship
between severity of anxiety/depression and duration of symp-
toms. We found a stronger relationship between maternal anxiety
symptoms and asthma when anxiety symptoms had been present
for longer, but this is likely to be explained by a severity effect so
that mothers who reported continuing anxiety symptoms to the
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OR (95% CI) for asthma at 7½ y OR (95% CI) for asthma with BHR
N asthma/no asthma
(% with asthma) Crude Adjusted*
N asthma/no asthma
(% with asthma) Crude Adjusted*
Maternal anxiety at 18 wk
1st quartile (0-2) 198/1734 (10.2%) 1 (reference) 1 (reference) 38/1734 (2.1%) 1 (reference) 1 (reference)
2nd quartile (3-4) 174/1176 (12.9%) 1.30 (1.04-1.61) 1.24 (1.00-1.55) 33/1176 (2.7%) 1.28 (0.80-2.05) 1.22 (0.76-1.97)
3rd quartile (5-7) 200/1295 (13.4%) 1.35 (1.10-1.67) 1.32 (1.07-1.63) 29/1295 (2.2%) 1.02 (0.63-1.67) 0.99 (0.60-1.62)
4th quartile (8-16) 163/870 (15.8%) 1.64 (1.31-2.05) 1.53 (1.22-1.93) 24/870 (2.7%) 1.26 (0.75-2.11) 1.24 (0.73-2.11)
P (trend) <.001 <.001 .6 .6
Maternal anxiety at 32 wk
1st quartile (0-2) 168/1582 (9.6%) 1 (reference) 1 (reference) 27/1582 (1.7%) 1 (reference) 1 (reference)
2nd quartile (3-4) 185/1232 (13.1%) 1.41 (1.13-1.77) 1.36 (1.09-1.71) 29/1232 (2.3%) 1.38 (0.81-2.34) 1.35 (0.79-2.30)
3rd quartile (5-7) 204/1308 (13.5%) 1.47 (1.18-1.82) 1.42 (1.14-1.77) 35/1308 (2.6%) 1.57 (0.94-2.60) 1.55 (0.93-2.58)
4th quartile 8-16) 178/953 (15.7%) 1.76 (1.40-2.20) 1.65 (1.30-2.08) 33/953 (3.3%) 2.03 (1.21-3.40) 2.09 (1.24-3.53)
P (trend) <.001 <.001 .006 .005
*Adjusted for sex, preterm delivery, multiple birth, number of siblings, maternal age, maternal education, maternal history of asthma and allergy, prenatal tobacco smoke exposure,
and problems during pregnancy (diabetes, hypertension, steroid intake).
TABLE III. Relationship between maternal anxiety symptoms reported before (32 weeks of gestation) and after birth (8 months) and
asthma in children age 7½ years
OR (95% CI) for current asthma at 7½ y
N asthma/no asthma
(% with asthma) Crude Adjusted*
Adjusted for confounders* and
for prenatal or postnatal anxiety
Maternal anxiety at 32 wk
gestation
1st quartile (0-2) 156/1529 (9.3%) 1 (reference) 1 (reference) 1 (reference)
2nd quartile (3-4) 166/1184 (12.3%) 1.37 (1.09-1.73) 1.33 (1.05-1.68) 1.31 (1.03-1.67)
3rd quartile (5-7) 193/1251 (13.4%) 1.51 (1.21-1.89) 1.46 (1.16-1.83) 1.42 (1.11-1.81)
4th quartile (8-16) 164/900 (15.4%) 1.79 (1.41-2.26) 1.68 (1.32-2.13) 1.64 (1.25-2.17)
P (trend) <.001 <.001 <.001
Maternal anxiety at 8 mo after
birth
1st quartile (0-2) 196/1668 (10.5%) 1 (reference) 1 (reference) 1 (reference)
2nd quartile (3-4) 188/1427 (11.6%) 1.12 (0.91-1.39) 1.09 (0.88-1.35) 0.99 (0.80-1.24)
3rd quartile (5-7) 138/795 (14.8%) 1.48 (1.17-1.87) 1.40 (1.10-1.77) 1.18 (0.92-1.53)
4th quartile (8-16) 157/974 (13.9%) 1.37 (1.10-1.72) 1.26 (1.00-1.59) 0.99 (0.76-1.29)
P (trend) <.001 .01 .7
*Adjusted for sex, preterm delivery, multiple birth, number of siblings, maternal age, maternal education, maternal history of asthma and allergy, prenatal tobacco smoke exposure,
and problems during pregnancy (diabetes, hypertension, steroid intake).postnatal period had higher antenatal anxiety scores and severe
prenatal anxiety is more likely to be associated with persistence
of symptoms. When we adjusted postnatal associations between
maternal anxiety symptoms and asthma in childhood for the
prenatal measures, the effect was attenuated completely.
Another difference between our approach and previous studies
was the use of anxiety symptoms alone rather than a combination
of anxiety and depression as the primary exposure. This decision
was reached on the basis of exploratory analyses of the relative
contributions of reported anxiety and depression symptoms to the
association with the primary outcome, in which we found that the
inclusion of prenatal depression scores did not affect the associ-
ation between anxiety symptoms and childhood asthma, and no
independent association between childhood asthma and maternal
reported depression symptoms was detected. In addition, others
have reported associations between maternal anxiety in the
prenatal period and childhood outcomes that would be consistent
with an intrauterine effect of maternal stress on altered fetal
physiology in this population.25-27 We believe our data to beconsistent with an antenatal programming effect, although the
precise mechanism of this has still to be explained. We carefully
considered the possibility that this observation was confounded
by adjusting for a large number of variables known to be associ-
ated with asthma and by using the anxiety symptom score of the
mother’s partner as a further test of confounding.28 If there was a
true intrauterine effect, we would expect the observed association
to be considerably stronger for the mother’s than for the partner’s
anxiety, which is what our analyses indicated. One of the possible
confounding variables considered by Kozyrskyj et al12 but not by
us was the attendance of the child at day care. Although it might
be supposed that mothers with higher reported levels of anxiety
symptomswould be less likely to send their young children to pre-
school day care, the reported protective association of day care
with subsequent asthma29 in children would be expected to atten-
uate associations between anxiety symptoms and asthma. How-
ever, there are discrepant findings that suggest day care
attendance may increase the risk of asthma, at least in young chil-
dren,30 and the associations between day care and asthma may be
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could not discount the possibility of spurious associations arising
through this source of confounding. However, in post hoc analy-
ses, we found no evidence of a relationship betweenmaternal anx-
iety scores and reported day care attendance by their children (see
this article’s Table E9 in the Online Repository at www.
jacionline.org).
Our study has several strengths, including recruitment during
pregnancy, enabling the prospective ascertainment of maternal
anxiety and depression symptoms, thus making the possibility of
recall bias or reverse causation unlikely. The use of an objective
measure of bronchial hyperresponsiveness also increased the
association with anxiety at 32 weeks, presumably because of less
measurement error in the outcome. However, in common with
many large, population-based longitudinal surveys,32 there was a
considerable loss of data, because of either incomplete ascertain-
ment or loss to follow-up. Those with incomplete data were more
likely to come from socially disadvantaged backgrounds and had
evidence of higher maternal anxiety scores compared with the
population with complete data. This introduces the possibility
of selection bias, but one would have to postulate that the associ-
ation between anxiety and asthma in subjects with missing data
operated in the opposite direction (anxiety symptoms associated
with reduced risk of asthma) to abolish the observed association,
which seems unlikely. Furthermore, adjustment for a range of
variables associated with social disadvantage produced very little
attenuation of effect sizes in our primary analyses.
Another potential weakness of this study was the reliance on
maternal self-report to define anxiety and depression symptoms.
The scales used have been validated previously for self-comple-
tion, and these measures have been associated with a number of
clinical and biochemical outcomes in a sample of our study
population.17 Because recall bias is not possible, any measure-
ment error is likely to be random and hence will make our ob-
served associations conservative. Also, although we reported
positive associations of maternal anxiety symptoms with asthma,
the interpretation for these findings must be viewed with some
caution. We were unable to ascertain the biological sources of
anxiety in the women in our study and had no maternal or fetal
biomarker data to confirm anxiety had a biological effect in this
population. There is also the possibility of residual confounding
through unmeasured social or lifestyle variables, although we
found little evidence of attenuation with the markers that were
considered in this study.
Wright et al33 identified associations between caregiver stress
in early childhood and allergic responses in infants predisposed
to asthma or atopy. It was suggested these were related to changes
in neuroendocrine function, in particular through the HPA axis,
and might influence immune development through alterations
of cytokine responses.34 Another possiblemechanism for a prena-
tal programming effect is through epigenetic regulation of the
glucocorticoid receptor gene, which has been shown to occur in
human beings.35 Emerging evidence suggests that environmental
variables may alter methylation profiles of other genes of rele-
vance to asthma,36 opening the possibility that maternal stress
could operate through direct epigenetic effects, as well as indirect
effects mediated through neuroendocrine dysregulation. Kozyr-
skyj et al12 reported effects of continued stress beyond the perina-
tal period on childhood asthma. It is possible to reconcile these
results with our observations if postnatal behaviors modify the ef-
fects of prenatal anxiety,37 such as changing emotionalattachments to the newborn infant, which could alter postpartum
cortisol levels38; although in primate studies, high prenatal levels
were associated with more attentive infant care behaviors. Early
caregiving behavior can also modify neurobiological responses,
including the response of the HPA axis to stressful stimuli.39
Thus, prenatal programming and postnatal behavioral modifica-
tion could operate through similar pathways to influence fetal
and child development.
Our data support an independent effect of prenatal exposure to
maternal anxiety on the development of asthma during childhood,
although we can only speculate on the mechanisms of this
association, and we hope in future studies to have biomarker data
on cortisol responses in children to explore this further.We did not
find evidence to suggest a stronger association in subjects
reporting atopic asthma, suggesting that the association between
maternal anxiety and asthma is not mediated directly through
influences on allergic sensitization. There has been a continuing
interest in pregnancy as a critical period in the development of
asthma in children, and emerging evidence supports the possi-
bility of programming effects of maternal stress in pregnancy on
several childhood outcomes. The development of relatively
straightforward interventions to reduce maternal stress in preg-
nancy makes it possible to test these hypothetical relationships in
a controlled trial.40 Although it is too early to advocate specific
interventions aimed at primary prevention of asthma, we would
suggest that asthma and allergic outcomes are included if inter-
vention studies to reduce anxiety and distress during pregnancy
are considered.
We are extremely grateful to all the families who took part in this study, the
midwives for their help in recruiting them, and the whole ALSPAC team,
which includes interviewers, computer and laboratory technicians, clerical
workers, research scientists, volunteers, managers, receptionists, and nurses.
Clinical implications: These results indicate a biologically plau-
sible risk factor for asthma that is amenable to prenatal
intervention.
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To explore the possible differences between anxiety trait and reactive
anxiety to recent life events, we used a life events inventory administered to
pregnant women at 18 weeks of gestation. This considered the occurrence of
42 events (Appendix E1) since pregnancy onset, modeled on a previously re-
ported life events inventory.E1 A weighted life events score was derived by
summing the self-reported impact of each event as follows: affected a lot 5
4; fairly affected5 3; mildly affected5 2; no effect at all5 1; and if the event
did not happen, it was coded5 0. Women in the lowest quartile of life events
score (score5 0-2) were categorized as anxiety trait (nonreactive), and those
in the upper 3 quartiles were categorized as having reactive anxiety symptoms.
Associations with children’s asthma for each of these categories and the inter-
action between anxiety symptom scores and life events on childhood asthma
were tested.
To consider the timing of exposure to maternal anxiety, we created 4
mutually exclusive groups based on prenatal (32 weeks of gestation) and
postnatal (8months after birth) anxiety scores.Womenwhose anxiety score on
the Crown-Crisp Experiential Index was greater than the group median score
for each period were classed as anxiety present and those below the median as
anxiety absent for each period. The relationship between each anxiety
category and asthma at age 7½ years: prenatal only (32 weeks and not 8
months), postnatal only (8 months and not 32 weeks), and both (32 weeks and
8 months) were compared with those without anxiety at either period using
logistic regression analysis.
To consider the possibility that the relationship between maternal anxiety
reported in the antenatal period was confounded by variables other than those
that were used in the adjusted multivariable analysis, we considered the
mother’s partner’s anxiety score at 18 weeks of gestation as an adjustment
variable. If therewas a true intrauterine effect, wewould expect the association
with asthma to be stronger for maternal anxiety than for paternal anxiety.E2
Reported anxiety scores for mother and partner at 18 weeks of gestation
were dichotomized above and below the median value for each group of sub-
jects. Fourmutually exclusive groups were created: neither mother nor partner
anxious, mother only anxious, partner only anxious, and bothmother and part-
ner anxious. The association between each anxiety category and asthma at age
7½ years was compared with the neither category by logistic regression.
To determinewhether the relationship betweenmaternal anxiety scores and
asthma at age 7½ years was likely to be mediated through anxious mothers
having more anxious children, we used the emotional difficulties subscale of
the Strengths and Difficulties QuestionnaireE3 as a measure of internalizing
symptoms. The questionnaire was posted as part of a larger self-completion
questionnaire to mothers when their children were approximately 4 years
(47 months) old. The responses were divided into 3 quantiles, and the relation-
ship between these and subsequent asthma at age 7½ years was analyzed by
using logistic regression.
To test for reporting bias, associations between maternal anxiety and 2
common childhood problems (earache and accidents), in addition to reported
wheeze, obtained from self-completion questionnaires sent to the mother at 18
months (covering the period 6-18months) and 81months (covering the period
69-81 months). For each problem the mother was asked about its occurrence
(yes/no) and if yes, whether she took the child to see a doctor. The occurrence
of each problem during each of the 2 periods was compared across quartiles of
maternal anxiety scores during early (18 weeks) and late (32 weeks) gestation
of pregnancy. Logistic regression was used to determinewhether mothers with
greater anxiety scores were more likely to present their child to a doctor with
each problem by comparing each anxiety quartile with the lowest quartile for
that period.
All analyses were performed by using Stata v10 (StataCorp, College
Station, Texas).
RESULTS
Table E1 shows the associations of children’s asthma at age 7½
years with maternal anxiety at 18 weeks of gestation stratified by
anxiety trait and reactive anxiety. Nonreactive anxiety symptoms
(anxiety trait) was more strongly associated with children’sasthma for all levels of anxiety symptom scores, but there was
weak evidence of an interaction between anxiety symptoms and
life events on children’s asthma risk (P 5 .4).
Analysis of timing of exposure showed that anxiety in both
prenatal and postnatal periods was more strongly associated with
asthma (OR, 1.46; 95% CI, 1.20-1.78) than during either prenatal
(OR, 1.30; 95% CI, 1.04-1.64) or postnatal (OR, 1.18; 95% CI,
0.89-1.57) alone. However, further exploration of this relation-
ship suggested that it was confounded by severity; women
reporting anxiety in both periods had higher anxiety scores at
32 weeks than those with anxiety at 32 weeks only (Table E5).
Adjustment of associations of maternal prenatal anxiety with
asthma by the mother’s partner’s reported anxiety at 18 weeks of
gestation (Table E6) showed no association between anxiety and
asthma if only the partner reported anxiety (OR, 0.94; 95% CI,
0.73-1.20) compared with maternal anxiety alone at 18 weeks
of gestation (OR, 1.28; 95%CI, 1.00-1.63). However, if both part-
ners reported anxiety (abovemedian score) at 18 weeks, the effect
was marginally stronger (OR, 1.33; 95% CI, 1.04-1.68). This re-
lationship was confounded by severity of maternal anxiety, with
more anxious women being more likely to have anxious partners
(Table E7).
There was no evidence that the association between maternal
anxiety and childhood asthma was mediated through children’s
internalizing symptoms. The OR (95% CI) for the highest tertile
of the emotional symptom subscale of the Strengths and Diffi-
culties Questionnaire in children age 47 months (compared with
lowest tertile) was 1.21 (0.98-1.48; P [trend] 5 0.1).
Table E8 shows the proportions of children reported to have
been taken to the doctor for wheeze, earache, or accidents in
the periods 6 to 18months and 69 to 81months. Therewas no con-
sistent pattern of increased numbers of children with each prob-
lem being reported in the higher quartiles of reported maternal
anxiety scores at either 18 or 32 weeks of gestation. There was
a tendency for mothers with higher anxiety scores to present
younger children to doctors for accidents, but this appeared to re-
verse for the presentation of older children (69-81 months). There
was also increased presentation of young children with wheeze in
the highest quartile of maternal anxiety at 18 weeks but not at 32
weeks. For earache, it appeared that more anxious mothers were
less likely to take young children to the doctor.
Table E9 shows an absence of association between reported
maternal anxiety during pregnancy (32 weeks) or after birth (8
months) with whether their child attended day care.
APPENDIX E1
ITEMS IN THE LIFE EVENT INVENTORY
ADMINISTERED TO PREGNANT WOMEN AT 18
WEEKS OF GESTATION
1. Your partner died
2. One of your children died
3. A friend or relative died
4. One of your children was ill
5. Your partner was ill
6. A friend or relative was ill
7. You were admitted to hospital
8. You were admitted to hospital
9. You were divorced
10. You found that your partner didn’t want your child
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12. Your partner lost his job
13. Your partner had problems at work
14. You had problems at work
15. You lost your job
16. Your partner went away
17. Your partner was in trouble with the law
18. You and your partner separated
19. Your income was reduced
20. You argued with your partner
21. You had arguments with your family or friends
22. You moved house
23. Your partner hurt you physically
24. You became homeless
25. You had a major financial problem
26. You got married
27. Your partner hurt your children physically
28. You attempted suicide
29. You were convicted of an offense
30. You were bleeding and thought you might miscarry
31. You started a new job
32. You had a test to see if your baby was abnormal33. You had a result on a test that suggested your baby might
not be normal
34. You were told that you were going to have twins
35. You heard that something that had happened might be
harmful to the baby
36. You tried to have an abortion
37. You took an examination
38. Your partner was emotionally cruel to you
39. Your partner was emotionally cruel to your children
40. Your house or car was burgled
41. You had an accident
42. Is there anything else which is not on the list which has
concerned you or required additional effort from you to
cope since becoming pregnant?
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853.e3 COOKSON ET ALTABLE E1. Associations of maternal anxiety symptoms at 18 weeks of gestation (stratified by reactive and nonreactive to life events)
with children’s asthma at 7½ years
OR (95% CI) for current asthma at 7½ y
N asthma/no asthma
(% with asthma) Crude Adjusted*
Maternal reactive anxiety at 18 wk
1st quartile (0-2) 99/781 (11.3) 1 (reference) 1 (reference)
2nd quartile (3-4) 100/661 (13.1) 1.19 (0.89-1.61) 1.13 (0.84-1.53)
3rd quartile (5-7) 131/845 (13.4) 1.22 (0.93-1.62) 1.20 (0.90-1.59)
4th quartile (8-16) 127/660 (16.1) 1.52 (1.14-2.01) 1.38 (1.03-1.85)
P (trend) .005 .029
Maternal anxiety trait at 18 wk
1st quartile (0-2) 99/948 (9.5) 1 (reference) 1 (reference)
2nd quartile (3-4) 73/512 (12.5) 1.37 (0.99-1.88) 1.33 (0.96-1.85)
3rd quartile (5-7) 68/444 (13.3) 1.47 (1.06-2.04) 1.46 (1.04-2.05)
4th quartile (8-16) 36/207 (14.8) 1.67 (1.11-2.51) 1.71 (1.12-2.62)
P (trend) .004 .004
*Adjusted for sex, preterm delivery, multiple birth, number of siblings, maternal age, maternal education, maternal history of asthma and allergy, prenatal tobacco smoke exposure,
and problems during pregnancy (diabetes, hypertension, steroid intake).
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7½ years
OR (95% CI) for atopic
asthma at 7½ y
OR (95% CI) for nonatopic
asthma at 7½ y
N asthma/no asthma
(% with asthma) Crude Adjusted*
N asthma/no asthma
(% with asthma) Crude Adjusted*
Maternal anxiety at 18 wk
1st quartile (0-2) 80/1734 (4.4%) 1 (reference) 1 (reference) 66/1734 (3.7%) 1 (reference) 1 (reference)
2nd quartile (3-4) 72/1176 (5.8%) 1.33 (0.96-1.84) 1.27 (0.91-1.77) 42/1176 (3.4%) 0.94 (0.63-1.39) 0.92 (0.62-1.37)
3rd quartile (5-7) 68/1295 (5%) 1.14 (0.82-1.59) 1.11 (0.79-1.56) 58/1295 (4.3%) 1.18 (0.82-1.69) 1.17 (0.81-1.68)
4th quartile 8-16) 51/870 (5.5%) 1.27 (0.89-1.82) 1.20 (0.83-1.74) 62/870 (6.7%) 1.87 (1.31-2.67) 1.78 (1.24-2.57)
P (trend) .3 .4 <.001 .002
Maternal anxiety at 32 wk
1st quartile (0-2) 70/1582 (4.2%) 1 (reference) 1 (reference) 47/1582 (2.9%) 1 (reference) 1 (reference)
2nd quartile (3-4) 62/1232 (4.8%) 1.14 (0.80-1.61) 1.08 (0.76-1.54) 59/1232 (4.6%) 1.61 (1.09-2.38) 1.57 (1.06-2.33)
3rd quartile (5-7) 76/1308 (5.5%) 1.31 (0.94-1.83) 1.27 (0.90-1.77) 68/1308 (4.9%) 1.75 (1.20-2.56) 1.72 (1.17-2.51)
4th quartile 8-16) 63/953 (6.2%) 1.49 (1.05-2.12) 1.43 (1.00-2.05) 54/953 (5.4%) 1.91 (1.28-2.84) 1.80 (1.20-2.70)
P (trend) .02 .03 .001 .003
*Adjusted for sex, preterm delivery, multiple birth, number of siblings, maternal age, maternal education, maternal history of asthma and allergy, prenatal tobacco smoke exposure,
and problems during pregnancy (diabetes, hypertension, steroid intake)
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OR (95% CI) for allergy at 7½ y
N allergy/no allergy
(% with allergy) Crude Adjustedy
Maternal anxiety symptoms at 18 wk
1st quartile (0-2) 384/1387 (21.7) 1 (reference) 1 (reference)
2nd quartile (3-4) 255/1058 (19.4) 0.87 (0.73-1.04) 0.86 (0.72-1.03)
3rd quartile (5-7) 310/1121 (21.7) 1.00 (0.84-1.18) 1.00 (0.84-1.19)
4th quartile (8-16) 215/865 (19.9) 0.90 (0.74-1.08) 0.95 (0.78-1.15)
P (trend) .50 .87
Maternal anxiety symptoms at 32 wk
1st quartile (0-2) 372/1277 (22.6) 1 (reference) 1 (reference)
2nd quartile (3-4) 282/1138 (19.9) 0.85 (0.71-1.01) 0.88 (0.74-1.05)
3rd quartile (5-7) 292/1237 (19.1) 0.81 (0.68-0.96) 0.83 (0.70-0.99)
4th quartile (8-16) 260/911 (21.6) 0.98 (0.82- 1.17) 1.06 (0.88-1.27)
P (trend) .47 .99
*Allergy defined as positive skin prick test result to 1 of cat/grass/house dust mite.
Adjusted for sex, preterm delivery, multiple birth, number of siblings, maternal age, maternal education, maternal history of asthma and allergy, prenatal tobacco smoke exposure,
and problems during pregnancy (diabetes, hypertension, steroid intake).
J ALLERGY CLIN IMMUNOL
VOLUME 123, NUMBER 4
COOKSON ET AL 853.e6TABLE E4. Association between maternal anxiety symptoms and bronchial hyperresponsiveness* in children
OR (95% CI) for bronchial hyperresponsiveness (BHR) at 8½ y
N BHR/no BHR (% with BHR) Crude Adjustedy
Maternal anxiety symptoms at 18 wk
1st quartile (0-2) 197/1051 (15.8) 1 (reference) 1 (reference)
2nd quartile (3-4) 139/773 (15.2) 0.96 (0.76-1.21) 0.95 (0.75-1.20)
3rd quartile (5-7) 146/807 (15.3) 0.97 (0.76-1.22) 0.96 (0.76-1.21)
4th quartile (8-16) 120/555 (17.8) 1.15 (0.90-1.48) 1.15 (0.89-1.48)
P (trend) .39 .42
Maternal anxiety symptoms at 32 wk
1st quartile (0-2) 190/1004 (15.9) 1 (reference) 1 (reference)
2nd quartile (3-4) 143/804 (15.1) 0.94 (0.74-1.19) 0.95 (0.75-1.21)
3rd quartile (5-7) 158/871 (15.4) 0.96 (0.76-1.21) 0.97 (0.77-1.22)
4th quartile (8-16) 130/618 (17.4) 1.11 (0.87-1.42) 1.14 (0.89-1.46)
P (trend) .50 .41
*Bronchial hyperresponsiveness defined as PD20 <1.2 mg methacholine.
Adjusted for sex, preterm delivery, multiple birth, number of siblings, maternal age, maternal education, maternal history of asthma and allergy, prenatal tobacco smoke exposure,
and problems during pregnancy (diabetes, hypertension, steroid intake).
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853.e7 COOKSON ET ALTABLE E5. Comparison of proportions in upper quartiles of maternal anxiety symptoms at 32 weeks for women with reported prenatal
anxiety* alone or with prenatal and postnatal anxiety*
Maternal anxiety at 32 wk
3rd quartile (5-7) 4th quartile (8-16)
Accumulated maternal anxiety
32 wk pregnancy only 720 (70%) 302 (30%)
32 wk pregnancy and 8 mo 724 (49%) 762 (51%)
*Greater than median value for each period. N (%) in table refers to number of women (%) in the upper two quartiles of anxiety symptoms scores at 32 weeks of gestation.
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COOKSON ET AL 853.e8TABLE E6. Association of mothers’ and partners’ anxiety symptom scores at 18 weeks of gestation and current asthma in children at 7½
years
OR (95% CI) for current asthma at 7½ y
N asthma/no asthma
(% with asthma) Crude Adjusted
Combined parental anxiety at 18 weeks gestation*
Neither parent anxious 173/1384 (11.1%) 1 (reference) 1 (reference)
Only partner anxious 121/994 (10.9%) 0.97 (0.76-1.25) 0.94 (0.73-1.20)
Only mother anxious 137/836 (14.1%) 1.31 (1.03-1.67) 1.28 (1.00-1.63)
Both parents anxious 154/889 (14.8%) 1.39 (1.10-1.75) 1.33 (1.04-1.68)
P (trend) .001 .005
*Anxiety defined as present if score above median.
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853.e9 COOKSON ET ALTABLE E7. Distribution of mothers’ and their partners’ anxiety symptom categories at 18 weeks of gestation
Paternal anxiety at 18 wk (%)
1st quartile (0-1) 2nd quartile (2) 3rd quartile (3-4) 4th quartile (5-12)
Maternal anxiety at 18 wk
1st quartile (0-2) 44.0 16.8 19.5 19.8
2nd quartile (3-4) 38.4 16.3 21.0 24.2
3rd quartile (5-7) 35.1 15.6 22.6 26.7
4th quartile (8-16) 29.8 14.9 24.7 30.6
TABLE E8. Doctor consultations for common childhood problems in early and late childhood according to maternal prenatal anxiety symptom scores
95% CI) for earache OR (95% CI) for accident
Crude Adjusted for sex N (%) Crude Adjusted for sex
.0 (reference) 1.0 (reference) 356/567 (62.8) 1.0 (reference) 1.0 (reference)
.69 (0.48-0.97) 0.69 (0.48-0.97) 294/456 (64.5) 1.08 (0.83-1.39) 1.08 (0.83-1.40)
.83 (0.59-1.18) 0.83 (0.59-1.18) 386/584 (66.1) 1.16 (0.91-1.47) 1.16 (0.91-1.47)
.56 (0.40-0.78) 0.56 (0.40-0.78) 354/490 (72.2) 1.54 (1.19-2.0) 1.55 (1.19-2.01)
004 .004 .002 .001
.0 (reference) 1.0 (reference) 318/444 (71.6) 1.0 (reference) 1.0 (reference)
.01 (0.82-1.25) 1.01 (0.82-1.25) 208/317 (65.6) 0.76 (0.55-1.03) 0.75 (0.55-1.03)
.03 (0.84-1.25) 1.03 (0.82-1.25) 271/416 (65.1) 0.74 (0.55-0.99) 0.74 (0.55-0.99)
.22 (0.97-1.53) 1.22 (0.97-1.53) 196/313 (62.6) 0.66 (0.49-0.90) 0.66 (0.49-0.90)
12 .12 .009 .009
.0 (reference) 1.0 (reference) 325/526 (61.8) 1.0 (reference) 1.0 (reference)
.83 (0.59-1.17) 0.83 (0.59-1.16) 333/497 (67.0) 1.26 (0.97-1.62) 1.26 (0.97-1.62)
.83 (0.60-1.15) 0.83 (0.60-1.15) 376/579 (64.9) 1.15 (0.90-1.46) 1.15 (0.90-1.46)
.72 (0.52-1.0) 0.72 (0.52-1.0) 394/556 (70.8) 1.50 (1.17-1.94) 1.50 (1.17-1.94)
06 .06 .006 .006
.0 (reference) 1.0 (reference) 286/405 (70.6) 1.0 (reference) 1.0 (reference)
.06 (0.86-1.31) 1.06 (0.86-1.31) 247/366 (67.5) 0.86 (0.64-1.17) 0.86 (0.63-1.17)
.04 (0.85-1.27) 1.04 (0.85-1.27) 275/409 (67.2) 0.85 (0.63-1.15) 0.85 (0.63-1.15)
.23 (0.99-1.54) 1.23 (0.99-1.54) 212/355 (59.7) 0.62 (0.46-0.83) 0.62 (0.46-0.83)
10 .10 .003 .003
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1
0OR (95% CI) for wheezing OR (
N (%) Crude Adjusted for sex N (%)
Maternal anxiety at 18 wk Symptoms between 6 and 18 mo
1st quartile (0-2) 758/912 (83.1) 1.0 (reference) 1.0 (ref) 924/988 (93.5) 1
2nd quartile (3-4) 611/732 (83.5) 1.03 (0.79-1.33) 1.03 (0.79-1.34) 733/807 (90.8) 0
3rd quartile (5-7) 770/914 (84.2) 1.09 (0.85-1.39) 1.09 (0.85-1.40) 903/978 (92.3) 0
4th quartile (8-16) 735/848 (86.7) 1.32 (1.02-1.72) 1.33 (1.02-1.73) 773/868 (89.1) 0
P trend .04 .04 .
Maternal anxiety at 18 wk Symptoms between 69 and 81 mo
1st quartile (0-2) 243/351 (69.2) 1.0 (reference) 1.0 (reference) 739/1016 (72.7) 1
2nd quartile (3-4) 205/314 (65.3) 0.84 (0.60-1.16) 0.83 (0.60-1.15) 567/777 (73.0) 1
3rd quartile (5-7) 246/383 (64.2) 0.80 (0.59-1.09) 0.78 (0.57-1.07) 696/950 (73.3) 1
4th quartile (8-16) 213/310 (68.7) 0.98 (0.70-1.36) 0.97 (0.70-1.35) 527/689 (76.5) 1
P trend .74 .69 .
Maternal anxiety at 32 wk Symptoms between 6 and 18 mo
1st quartile (0-2) 658/793 (83.0) 1.0 (reference) 1.0 (reference) 858/927 (92.6) 1
2nd quartile (3-4) 624/749 (83.3) 1.02 (0.78-1.34) 1.03 (0.79-1.34) 762/836 (91.1) 0
3rd quartile (5-7) 812/971 (83.6) 1.05 (0.81-1.35) 1.05 (0.82-1.36) 931/1021 91.2) 0
4th quartile (8-16) 813/954 (85.2) 1.18 (0.91-1.53) 1.19 (0.92-1.54) 864/960 (90) 0
P trend .20 .19 .
Maternal anxiety at 32 wk Symptoms between 69 and 81 mo
1st quartile (0-2) 213/313 (68.1) 1.0 (reference) 1.0 (reference) 681/939 (72.5) 1
2nd quartile (3-4) 209/322 (64.9) 0.87 (0.62-1.21) 0.86 (0.61-1.19) 607/824 (73.7) 1
3rd quartile (5-7) 260/400 (65.0) 0.87 (0.64-1.19) 0.85 (0.62-1.16) 727/993 (73.2) 1
4th quartile (8-16) 249/351 (70.9) 1.15 (0.82-1.60) 1.13 (0.81-1.58) 583/762 (76.5) 1
P trend .43 .48 .
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853.e11 COOKSON ET ALTABLE E9. Distribution of maternal prenatal (32 weeks) and postnatal (8 months) anxiety symptom scores and day care attendance of
preschool child
Day care attendance Day care attendance
Yes No Total Yes No Total
N (%) N (%) N Maternal anxiety at 8 mo N (%) N (%) N
Maternal anxiety at 32 wk
1st quartile 180 (6.4) 2,647 (93.6) 2,827 1st quartile 192 (5.8) 3,114 (94.2) 3,306
2nd quartile 138 (5.9) 2,202 (94.1) 2,340 2nd quartile 187 (6.5) 2,699 (93.5) 2,886
3rd quartile 168 (6.4) 2,479 (93.6) 2,647 3rd quartile 100 (5.9) 1,602 (94.1) 1,702
4th quartile 115 (5.4) 2,033 (94.7) 2,148 4th quartile 144 (6.4) 2,114 (93.6) 2,258
9,962 10,152
